Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 694, pseudogene (RNU6-694P)** is a human pseudogene related to the U6 small nuclear RNA (snRNA) family[4]. U6 snRNA is a highly conserved non-coding RNA essential for pre-mRNA splicing as a core component of the spliceosome, but RNU6-694P itself is classified as a pseudogene, meaning it is a DNA sequence similar to a functional gene but generally non-functional, not encoding a protein, and presumed not to produce functional RNA[3]. While canonical U6 snRNA genes play a critical role in intron removal during mRNA maturation[1][3], pseudogenes like RNU6-694P may rarely be transcribed and can sometimes act in gene regulation via RNA interference mechanisms by acting as decoys or generating noncoding RNAs, though there is no published evidence for regulatory or disease roles for this specific pseudogene[2]. RNU6-694P is not considered a therapeutic target, and there are no known drugs or approved mechanisms of action involving this pseudogene[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 694, pseudogene (RNU6-694P).